Meclizine is neuroprotective in models of Huntington's disease

By Gohil Vishal M.   Offner Nicolas   Walker James A.   Sheth Sunil A.   Fossale Elisa   Gusella James F.   MacDonald Marcy E.   Neri Christian   Mootha Vamsi K.  

Human Molecular Genetics, Vol. 20, Iss. 2, 2011-01 ,pp. : 294-300

Oxford University Press

Access to resources Recommend Favorite

Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin

By Wang Hongmin   Lim Precious J.   Vogel Bruce E.   Monteiro Mervyn J.  

Human Molecular Genetics, Vol. 15, Iss. 6, 2006-03 ,pp. : 1025-1041

Oxford University Press

Access to resources Recommend Favorite

Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models

By Tauffenberger Arnaud   Chitramuthu Babykumari P.   Bateman Andrew   Bennett Hugh PJ.   Parker J. Alex  

Human Molecular Genetics, Vol. 22, Iss. 4, 2013-02 ,pp. : 782-794

Oxford University Press

Access to resources Recommend Favorite

Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models

By Phan Jack   Hickey Miriam A.   Zhang Peixiang   Chesselet Marie-Francoise   Reue Karen  

Human Molecular Genetics, Vol. 18, Iss. 6, 2009-03 ,pp. : 1006-1016

Oxford University Press

Access to resources Recommend Favorite

Orexin loss in Huntington's disease

By Petersén Åsa  

Human Molecular Genetics, Vol. 14, Iss. 1, 2005-01 ,pp. : 39-47

Oxford University Press

Access to resources Recommend Favorite